Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003501377 | SCV004268285 | uncertain significance | Glanzmann thrombasthenia | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change affects codon 451 of the ITGA2B mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the ITGA2B protein. This variant is present in population databases (rs762316789, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with ITGA2B-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |